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Abstract Expiratory pressure relief (C-Flex) technology
monitors the patient’s airflow during expiration and reduces
the pressure in response to the patient. Increased comfort
levels associated with C-Flex therapy have potential to
improve patient adherence to therapy. The purpose of this
study was to assess the combination of autoadjusting CPAP
(APAP) and C-Flex in terms of (1) treatment efficacy, and
(2) patient preference when compared to standard CPAP.
Fifteen patients who had previously undergone formal
CPAP titration polysomnography were treated with either
one night of the APAP with C-Flex or one night of
conventional CPAP, in a crossover trial. Patient satisfaction
levels were recorded using visual analog scales (VAS) on
the morning after the study. Mean patient age was 50±
12 years, body mass index (BMI) was 36±6 kg/m
2,
baseline AHI was 53±31 events/h, and CPAP Pressure
was 11±2 cm/H2O. APAP with C-Flex was as effective as
CPAP, with no differences detected in sleep latency (17±5
vs 12.3±3 min, p=0.4), or respiratory indices (AHI of 4.2±2
vs 2.4±0.7 events/h, p=0.1). VAS scores (scale 0–10)
indicated a trend towards increased patient satisfaction
while using APAP with C-Flex (7.9 vs 7.2, p=0.07). 10
patients expressed a preference for APAP with C-Flex
(VAS, 0 to10) over standard CPAP (total positive score of
68, mean score of 4.8±4.3). One patient expressed no
preference. Four patients expressed a preference for CPAP
(total positive score of 13, mean score of 0.9±1.9) (APAP
with C-Flex vs standard CPAP, p<0.01 paired t test). APAP
with C-Flex eliminates sleep disordered breathing as
effectively as standard CPAP. Patients indicated a prefer-
ence for APAP with C-Flex suggesting a possible advan-
tage in terms of patient adherence for this mode of
treatment.
Keywords CPAP.C-Flex.Auto-CPAP.Patientpreference
Introduction
Continuous positive airway pressure (CPAP) is the most
commonly prescribed treatment for patients with obstruc-
tive sleep apnea (OSA). CPAP is effective in reducing sleep
fragmentation, resolving nocturnal desaturation, and im-
proving daytime sleepiness [1]; moreover, CPAP is a cost-
effective use of healthcare resources, and may reduce risks
of motor vehicle crashes and the development of cardio-
vascular morbidity [2–5].
The efficacy of CPAP is compromised by relatively poor
compliance. A variety of measures have been shown to
improve compliance with CPAP; these include aggressive
follow-up of patients prescribed CPAP, group education,
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e-mail: najib.ayas@vch.caheated humidification, and mask adjustments [6–11].
Modifications in the algorithm, by which positive pressure
is delivered, have been attempted to improve comfort and
compliance with therapy.
A typical complaint by those using conventional CPAP
is that it is difficult to exhale against positive pressure.
Therefore, reducing pressure during exhalation may im-
prove tolerance with therapy. C-Flex (Respironics, Murrys-
ville, PA, USA) is a novel algorithm designed to provide
pressure relief during expiration, while maintaining optimal
pneumatic splinting for effective therapy.
Another modification is the development of autoadjust-
ing (APAP) devices. In contrast to conventional CPAP,
APAP devices modify applied pressure in response to
patient needs. APAP devices, through varied mechanisms,
are able to detect obstructive events and change pressure
accordingly to relieve the obstruction. This results in a
reduction in mean applied CPAP pressure [12], and may be
useful in patients who have difficulty tolerating CPAP.
Furthermore, APAP may be useful for ambulatory titration
of CPAP pressure in patients in whom in-laboratory therapy
titration is either delayed or impossible [13–15]. The
newest iteration of the REMStar Auto employs both the
REMStar Auto CPAP algorithm and the C-Flex dynamic
expiratory pressure relief.
This is the first study to evaluate the REMStar Auto with
C-Flex (RSA C-Flex) as a therapy for patients with OSA.
The major purpose of the study was to assess the ability of
RSA C-Flex to effectively treat the sleep apnea events.
Satisfaction and preference from the patients’ perspective,
and the number of required interactions per night by
technicians were also determined.
Materials and methods
Study subjects
Consecutive, recently diagnosed, adult patients (≥18 years
of age) with moderate to severe OSA [apnea hypopnea
index (AHI) >15 events/h of sleep as determined by PSG]
[16] were asked to participate in our study. All subjects had
a titration PSG that determined the effective pressure
(i.e., AHI <5 events/h during all sleep stages and positions).
All subjects were using conventional CPAP at home on a
regular basis with an average nightly usage >4 h, confirmed
by objective evaluation of CPAP machines. Exclusion
criteria included patients who were medically unstable,
using oxygen, had surgery of the upper airway or nose
within the previous 90 days, or who could not provide
informed consent.
The study was approved by the Ethics Board at the
University of British Columbia.
Procedures and techniques
Sleep laboratory rooms were configured with a device that
could deliver either conventional CPAP or RSA C-Flex.
The study occurred on two separate nights, within 2 weeks
of each other. For the first night, patients were randomized
to either conventional CPAP at the previously determined
effective pressure or RSA C-Flex. The patient was not
aware of which of the therapies they would be receiving.
However, the technician, by necessity, was aware of the
therapy choice. On the second experimental night, subjects
received the alternative therapy (crossover design).
For each night, all subjects were instrumented for
polysomnography and PAP titration according to practice
parameters published by the American Sleep Disorders
Association Standards of Practice Committee [17]. Chest
and abdominal excursion was measured using respiratory
impedence plethysmography (Respitrace; Ambulatory
Monitoring Equipment, Ardsley, New York, USA). Oxygen
saturation was recorded using a pulse oximeter (Model N-
100; Nellcor, Hayward, California, USA). Airflow was
measured directly from the CPAP machine. Respiratory
events were defined by standard criteria [16]. Obstructive
apneas were defined as absence of airflow for greater than
10 s. Obstructive hypopneas as a 50% decrease in airflow,
or a clear but lesser decrease in airflow if coupled with
either a desaturation of >3% or an arousal in the context of
ongoing respiratory effort. Central apneas were defined as
absence of airflow and respiratory effort for greater than
10 s. Central hypopneas as a 50% decrease in airflow with
concomitant reduction in respiratory effort, or a clear but
lesser decrease in airflow if coupled with either a desatura-
tion of >3% or an arousal. Arousals were counted per hour
of total sleep time. Sleep efficiency index was defined as
total sleep time/total time in bed.
Satisfaction with devices was assessed on the morning
after the study (see attached surveys, Appendix 1). All
subjects completed a visual analog satisfaction (VAS)
questionnaire. VAS scores are useful in assessing subjective
patient experience and have been used for this purpose in a
previous crossover trial comparing conventional CPAP and
APAP [18]. Patients scored satisfaction (0–10) with
different aspects of their experience from the previous
night. Questions included: (1) How well did you sleep last
night? (2) How rested do you feel this morning? (3) How
often did you wake during the night? (4) How uncomfort-
able was your CPAP pressure? (5) How difficult was it to
get to sleep? (6) Overall, how satisfied were you with your
quality of sleep last night? Mean score was calculated for
all 15 patients on both nights.
Preference for device was assessed on the morning after
the second experimental night. Subjects were asked “In
comparison to the first night of the study, please state a
32 Sleep Breath (2007) 11:31–37preference for the CPAP machine set-up”. Subjects were
asked to place a mark on a line to indicate the degree of
preference for the first night (0–10) or the second night
(0–10). Mean score was calculated for both nights, with a
score of less than 0 indicating preference for the other night.
The technicians recorded any required interactions with
the subject, during the night.
Conventional CPAP without C-Flex
CPAP pressure was set to the therapy pressure determined
during a previous titration study. A 20-min ramp was used
with the initial pressure being set as 66% of the previously
titrated pressure.
RSA with C-Flex
The REMStar Auto algorithm (Respironics, Murrysville,
PA, USA) is a proactive, flow-based algorithm. The basic
algorithm evaluates inspiratory flow, and determines
impending or actual flow limitation. This flow evaluation
occurs in concert with a program of pressure adjustments
designed to evaluate the critical pressures (at which airways
are susceptible to collapse) and resolve therapy pressures
slightly above these critical pressures. The patient is
protected from “break-through” events with a full comple-
ment of intelligent responses to airflow events and snoring.
C-Flex technology monitors the patient’s airflow during
expiration and reduces the pressure in response to the
patient. The relief pressure may vary on a breath-to-breath
basis, depending on the actual patient airflow (Fig. 1). The
device can be preset to deliver varying degrees of C-Flex
pressure relief (settings of 1–2–3).
RSA C-Flex was set at a minimum pressure of 66% of
previously titrated therapy pressure and a maximum
pressure of 20 cm H2O. Patients were arbitrarily set to a
C-Flex setting of 3 (maximum pressure relief). If the patient
commented about any sensation of “breathlessness” due to
the pressure relief, comfort settings were adjusted to 2 or 1
by the night technician.
Statistical analysis
Baseline characteristics were described using means and
standard deviations for continuous variables. Differences
between the CPAP and RSA C-Flex arms were compared
using paired t tests. Two-tailed tests were used to assess
significance (at the 0.05 level).
Results
Fifteen patients were included in the trial. Baseline char-
acteristics included (mean±SD) age 50±12 years, BMI 36±
6 kg/m
2. Overall, the patients had substantial sleep apnea
with a mean baseline AHI of 53±31 with a mean CPAP
pressure of 11±2 cm H20.
Results for the RSA C-Flex vs standard CPAP are shown
in Table 1. Overall, RSA C-Flex was as effective as
standard CPAP in relieving upper airway obstruction with a
mean AHI of 4.2 vs 2.4/h (p=0.1, Fig. 2). One patient had
central apneas during the RSA C-Flex night (index 10.2/h).
When these central events were excluded, the mean AHI
during the RSA C-Flex night decreased to 3.2 events/h
(Fig. 2). Furthermore, 12 out of 15 patients had an AHI of
less than five on the APAP night, which is similar to the
proportion on standard CPAP therapy (13/15). Measures of
sleep efficiency were similar between the groups. Although
patients had more slow-wave sleep during the RSAC night,
this was not statistically significant.
Patient satisfaction levels were measured using a visual
analog scale (Fig. 3). In general, VAS scores tended to be
higher on the RSA C-Flex night, although none of the
scales individually demonstrated a significant difference.
Fig. 1 Pressure relief is shown
on a breath by breath basis for
the three standard gain settings.
Pressure relief is dependant on
patient flow according to the
formulae—pdelivered=pbase−
prelief. prelief=(flow*gain)
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individual patients and compared using a paired t test, a
trend towards an increased score was noted in the C-Flex
group (7.9 vs 7.2, p=0.07, Fig. 4a).
In addition, patients were asked to rate their preference
for the treatment mode. Ten patients expressed a preference
for the RSAC night with the sum of positive scores
favoring the RSAC of 68 (mean 4.8±4.3). Four patients
expressed a preference for CPAP with the sum of positive
scores favoring CPAP of 13 (mean 0.9±1.9). One patient
expressed no preference. A significant difference was
found in preference between these two arms (paired t test,
p<0.01) (Fig. 4b).
Sleep technicians recorded the number of interactions
with each patient during the night. The majority of these
interactions were to adjust recording leads, and a minority
of occasions to adjust mask position. Technician interac-
tions did not differ between nights (1.4 vs 2.3 per night,
p=0.14).
Discussion
In our study, RSA C-Flex was as effective as standard
CPAP in treating sleep-disordered breathing. There were no
differences in sleep-related breathing or architecture vari-
ables between the arms. However, the RSA C-Flex arm was
associated with a trend in improvement in patient satisfac-
tion as assessed by VAS scores. Patients preferred RSA
C-Flex over standard CPAP.
To our knowledge, only one other published study has
looked at the use of C-Flex in OSA. In a nonrandomized
study of 89 patients, Aloia et al. [19] examined treatment
adherence in patients with OSA assigned to either standard
CPAP or C-Flex therapy. Clinical outcomes were measured
at 3 months and although functional outcomes associated
with sleep did not differ, adherence was significantly
greater in the C-Flex group (4.8 vs 3.1 h/night, p<0.01).
The crossover design of our trial using random treatment
order guaranteed patient matching while allowing us to
assess patient preference. Our study is not directly com-
parable to that of Aloia et al. as they examined long-term
compliance. However, our results are consistent in that our
two-night study demonstrated a preference of the patient for
RSA C-Flex.
Our findings are consistent with other studies of auto-
adjusting CPAP therapy. A metaanalysis of nine random-
ized controlled trials demonstrated that APAP is as effective
as standard CPAP in treating sleep apnea (in terms of
reducing apnea hypopnea index) [12]. Although this
metaanalysis did not demonstrate a significant improve-
ment in compliance with APAP, other studies have sug-
gested that APAP may be preferred by patients, especially if
their baseline CPAP pressures are elevated [20]. To control
this, we used 20-min ramps during CPAP nights in an
attempt to match initial pressures with the RSA C-Flex
night.
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Fig. 2 Mean oxygen saturation and AHI were compared between the
treatments. Mean AHI was 4.5 in the C-Flex arm, as compared to 2.5
in the standard CPAP arm (p=0.1). When central events were
excluded, this decreased to 3.5 in the C-Flex arm compared to 2.5 in
the CPAP arm (p=0.12)
Table 1 Outcomes with RSA C-Flex vs standard CPAP
RSA C-Flex CPAP P value
AHI (events/h) 4.2± 2.4±0.7 0.1
Sleep latency (min) 17.0±5 12.3±3 0.4
Sleep efficiency (%) 82±2 83±2 0.6
WASO (min) 67±14 65±12 0.9
REM % 25±2 24±2 0.7
Stage 3/4 (%) 4±1.5 1.6±0.5 0.13
Mean oxyhemoglobin
saturation (%)
97.3±0.3 97.2±0.3 0.93
PLMI (events/h) 2.8±1.0 3.8±1.5 0.59
Values given as mean±SEM
AHI Apnea hypopnea index, WASO wake after sleep onset, PLMI
periodic limb movement index
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effective as standard CPAP in reducing AHI. We noted that
one patient with a treatment AHI of >20 had a high
proportion of central sleep apnea. Review of this patient’s
diagnostic study revealed a very high baseline AHI (>100/h)
withthepresenceofcentralapneas(index>20/h).Assuchwe
feel that residual central apneas inthis patient reflect baseline
disease rather than being caused by RSA C-Flex. However,
thepossibility thattheRSA C-Flex maypredispose tocentral
events in a subgroup of patients cannot be excluded.
Patients preferred RSA C-Flex over standard CPAP, and
may have found it more comfortable. As such, we speculate
that RSA C-Flex may improve compliance if used as chronic
therapy. Furthermore, one of the major determinants of long-
term compliance with CPAP is the early experience with the
therapy. For many patients, in-laboratory titration represents
the first exposure of any duration to CPAP therapy
(Appendix 2). Any positive impact on this initial experience
has the potential to improve compliance in the longer term.
Use of RSA C-flex may thus be useful for initial titration of
CPAP in the laboratory. For similar reasons, RSA C-flex
may be useful in patients who are being titrated at home with
APAP. The impact of RSA C-Flex on long-term compliance
with chronic use, as “salvage” therapy of patients intolerant
of standard CPAP, or its utility as part of a laboratory/
ambulatory CPAP titration need to be studied in larger
clinical trials.
We acknowledge that there are a number of limitations
to our study. First, although the patient was not told of
the nightly treatment assignment, the technician was not
blinded. For our study, it was not possible for the
technician to be unaware of the treatment. Second, we
have studied a relatively small number of patients. Third,
we have only studied patients for two nights in the
laboratory and as such, we cannot extrapolate our study
to chronic treatment. We have not tested CPAP adherence
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Fig. 3 Visual analog scales were used to determine patient comfort levels. Scales ranged from 0–10 and were administered on the morning post
sleep study. Although VAS scores were higher on the C-Flex night, differences were not significant using a paired t test (p>0.1 for all outcomes)
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Fig. 4 a Mean VAS scores were calculated for individual patients and
compared using a paired t test. A trend towards increased score was
noted in the C-Flex group (7.9 vs 7.2, p=0.07). b Patient scored their
preference using VAS scores (1–10). A significant preference was
noted for C-Flex (p<0.01)
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hypothesis for future study—that use of the RSA C-Flex
may have a favorable effect on compliance. Finally, this
study included patients with predominately severe disease
who were compliant with CPAP. We may not be able to
extrapolate our results to patients with less severe sleep
apnea, or to patients with other concomitant respiratory
diseases (such as COPD).
Conclusion
In this small short-term study, both RSA C-Flex and
standard CPAP (with pressure defined by an in-laboratory
CPAP titration) were effective in treating sleep apnea. Most
patients preferred RSA C-flex. Future studies with this
technology are warranted to assess its effects on long-term
compliance and its potential as rescue therapy for those
initially noncompliant with standard CPAP therapy.
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Appendix 1
REMStar Auto with C-Flex—in-laboratory performance vs
conventionally titrated CPAP therapy: performance and
preferences
Patient questionnaire Night 1
Name________________________ Date___________
Thank you for completing the first night of our study.
Please take a moment to answer the following questions
1. How well did you sleep last night? Place a mark on
the line.
Scale:
0__________________________________________10
Slept terribly Slept extremely well
2. How rested do you fell this morning? Place a mark on
the line.
Scale:
0__________________________________________10
Not rested at all Extremely rested
3. How often did you wake during the night? Place a
mark on the line.
Scale:
0_________________________________________10
Woke very often Didn’t wake
4. How uncomfortable was your CPAP pressure? Place a
mark on the line.
Scale:
0_________________________________________10
Extremely uncomfortable Not uncomfortable
5. How difficult was it to get to sleep. Place a mark on
the line.
Scale:
0_________________________________________10
Extremely difficult Not difficult
6. Overall, how satisfied were you with your quality of
sleep last night. Place a mark on the line.
Scale:
0_________________________________________10
Extremely dissatisfied Extremely satisfied
Thank you for completing this survey.
Appendix 2
REMStar Auto with C-Flex—in-laboratory performance vs
conventionally titrated CPAP therapy: performance and
preferences
Patient questionnaire Night 2
Name________________________ Date___________
Thank you for completing the second night of our
study. Please take a moment to answer the following
questions
1. How well did you sleep last night? Place a mark on
the line.
Scale:
0_________________________________________10
Slept terribly Slept extremely well
2. How rested do you feel this morning? Place a mark on
the line.
Scale:
0_________________________________________10
Not rested at all Extremely rested
3. How often did you wake during the night? Place a
mark on the line.
Scale:
0_________________________________________10
Woke very often Didn’t wake
4. How uncomfortable was your CPAP pressure? Place a
mark on the line.
Scale:
0_________________________________________10
Extremely uncomfortable Not uncomfortable
5. How difficult was it to get to sleep. Place a mark on
the line.
Scale:
0_________________________________________10
Extremely difficult Not difficult
6. Overall, how satisfied were you with your quality of
sleep last night. Place a mark on the line.
Scale:
0_________________________________________10
Extremely dissatisfied Extremely satisfied
36 Sleep Breath (2007) 11:31–377. In comparison to the first night of the study please
state a preference for the CPAP machine set-up. Place a
mark on the line.
Scale:
10____________________0____________________10
Preferredfirstnight Nopreference Preferredsecondnight
Thank you for completing this survey.
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